Bioprocess Insider

More Topics
Japan halts Moderna vaccine doses due to CDMO contamination fears
Facilities & Capacity
Japan halts Moderna vaccine doses due to CDMO contamination fearsJapan halts Moderna vaccine doses due to CDMO contamination fears

Japan has put 1.6 million doses of the Moderna vaccine on hold after “foreign materials”  were discovered in approximately 565,000 vials.

byMillie Nelson
Sep 1, 2021
|
1 Min Read
Seqirus looks to next-gen mRNA for seasonal flu vaccine
Therapeutic Class
Seqirus looks to next-gen mRNA for seasonal flu vaccineSeqirus looks to next-gen mRNA for seasonal flu vaccine
byDan Stanton
Aug 31, 2021
1 Min Read
Biopharma playing second fiddle to chips and electronics in Samsung’s latest spending spree
Facilities & Capacity
Biopharma playing second fiddle to chips and electronics in Samsung’s latest spending spreeBiopharma playing second fiddle to chips and electronics in Samsung’s latest spending spree
byMillie Nelson
Aug 27, 2021
1 Min Read
Terumo and PhotonPharma partner to develop cancer vaccine
Deal-Making
Terumo and PhotonPharma partner to develop cancer vaccineTerumo and PhotonPharma partner to develop cancer vaccine
byMillie Nelson
Aug 27, 2021
1 Min Read
PBS to expand single-use bioreactor tech to feed cell therapy demand
Upstream & Downstream Processing
PBS to expand single-use bioreactor tech to feed cell therapy demandPBS to expand single-use bioreactor tech to feed cell therapy demand
byDan Stanton
Aug 27, 2021
1 Min Read
eBook: Cell and Gene Therapies &mdash; <br>A 2021 Industry Update
Therapeutic Class
eBook: Cell and Gene Therapies — A 2021 Industry UpdateeBook: Cell and Gene Therapies — A 2021 Industry Update
byDan Stanton, Gareth Macdonaldand 2 more
Aug 25, 2021
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Deal-Making
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Aug 25, 2021
|
1 Min Read
byMillie Nelson
Pfizer to acquire Trillium in $2.3bn deal
Deal-Making
Pfizer to acquire Trillium in $2.3bn deal
Pfizer to acquire Trillium in $2.3bn deal
Aug 25, 2021
|
1 Min Read
byMillie Nelson
EMA thumbs up to more CDMO sites supporting COVID vaccines
Regulations
EMA thumbs up to more CDMO sites supporting COVID vaccines
EMA thumbs up to more CDMO sites supporting COVID vaccines
Aug 25, 2021
|
1 Min Read
byDan Stanton
Lonza bulks up China offering with drug product plant
Facilities & Capacity
Lonza bulks up China offering with drug product plant
Lonza bulks up China offering with drug product plant
Aug 24, 2021
|
1 Min Read
byMillie Nelson
WuXi’s ongoing capacity drive ups planned MA investment to $300m
Global Markets
WuXi’s ongoing capacity drive ups planned MA investment to $300m
WuXi’s ongoing capacity drive ups planned MA investment to $300m
Aug 24, 2021
|
1 Min Read
byDan Stanton
Zymeworks on how to keep immune system at bay when developing bispecifics
Upstream & Downstream Processing
Zymeworks on how to keep immune system at bay when developing bispecifics
Zymeworks on how to keep immune system at bay when developing bispecifics
Aug 23, 2021
|
1 Min Read
byMillie Nelson
UK group says 3D printed automated control tech can cut mAb production costs
Upstream & Downstream Processing
UK group says 3D printed automated control tech can cut mAb production costs
UK group says 3D printed automated control tech can cut mAb production costs
Aug 23, 2021
|
1 Min Read
byGareth Macdonald
COVID continues to impact biopharma supply chains, survey
Global Markets
COVID continues to impact biopharma supply chains, survey
COVID continues to impact biopharma supply chains, survey
Aug 20, 2021
|
1 Min Read
byDan Stanton
Biotage triples lipid capacity to support mRNA vaccines
Facilities & Capacity
Biotage triples lipid capacity to support mRNA vaccines
Biotage triples lipid capacity to support mRNA vaccines
Aug 19, 2021
|
1 Min Read
byMillie Nelson
M&A rife in manufacturing space, driven by big CDMOs and PE
Deal-Making
M&A rife in manufacturing space, driven by big CDMOs and PE
M&A rife in manufacturing space, driven by big CDMOs and PE
Aug 19, 2021
|
1 Min Read
byDan Stanton
Polyplus reagent aims to ease CGT manufacturing issues
Upstream & Downstream Processing
Polyplus reagent aims to ease CGT manufacturing issues
Polyplus reagent aims to ease CGT manufacturing issues
Aug 18, 2021
|
1 Min Read
byMillie Nelson
Lilly hit by FDA 483 with 7 observations at IN plant
Regulations
Lilly hit by FDA 483 with 7 observations at IN plant
Lilly hit by FDA 483 with 7 observations at IN plant
Aug 17, 2021
|
1 Min Read
byDan Stanton
Moderna inks deal to build mRNA facility in Canada
Facilities & Capacity
Moderna inks deal to build mRNA facility in Canada
Moderna inks deal to build mRNA facility in Canada
Aug 13, 2021
|
1 Min Read
byMillie Nelson
Rentschler doubling commercial capacity through US expansion
Facilities & Capacity
Rentschler doubling commercial capacity through US expansion
Rentschler doubling commercial capacity through US expansion
Aug 13, 2021
|
1 Min Read
byDan Stanton
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Facilities & Capacity
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Aug 13, 2021
|
1 Min Read
byMillie Nelson
Artiva to build Californian NK cell therapy manufacturing facility
Facilities & Capacity
Artiva to build Californian NK cell therapy manufacturing facility
Artiva to build Californian NK cell therapy manufacturing facility
Aug 12, 2021
|
1 Min Read
byMillie Nelson
MaxCyte to support Sana’s ex vivo cell therapy plans
Deal-Making
MaxCyte to support Sana’s ex vivo cell therapy plans
MaxCyte to support Sana’s ex vivo cell therapy plans
Aug 12, 2021
|
1 Min Read
byMillie Nelson
Novavax: Analytical work keeping vaccine at bay, Fujifilm not to blame
Regulations
Novavax: Analytical work keeping vaccine at bay, Fujifilm not to blame
Novavax: Analytical work keeping vaccine at bay, Fujifilm not to blame
Aug 12, 2021
|
1 Min Read
byDan Stanton
Merck KGaA highlights MilliporeSigma as ‘star performer’ in Q2
Upstream & Downstream Processing
Merck KGaA highlights MilliporeSigma as ‘star performer’ in Q2
Merck KGaA highlights MilliporeSigma as ‘star performer’ in Q2
Aug 11, 2021
|
1 Min Read
byDan Stanton
BeiGene sets sights on US with NJ manufacturing facility
Facilities & Capacity
BeiGene sets sights on US with NJ manufacturing facility
BeiGene sets sights on US with NJ manufacturing facility
Aug 10, 2021
|
1 Min Read
byMillie Nelson
Appia partners with Kite to develop cell therapies for blood and bone cancers
Deal-Making
Appia partners with Kite to develop cell therapies for blood and bone cancers
Appia partners with Kite to develop cell therapies for blood and bone cancers
Aug 10, 2021
|
1 Min Read
byMillie Nelson
Podcast: GSK’s digital twin approach to vaccine development
Therapeutic Class
Podcast: GSK’s digital twin approach to vaccine development
Podcast: GSK’s digital twin approach to vaccine development
Aug 10, 2021
|
1 Min Read
byDan Stanton
Advanced Instruments buying cell line dev tech firm Solentim
Upstream & Downstream Processing
Advanced Instruments buying cell line dev tech firm Solentim
Advanced Instruments buying cell line dev tech firm Solentim
Aug 9, 2021
|
1 Min Read
byBPI Staff
MilliporeSigma: 'Viral vectors will dominate the next decade’
Upstream & Downstream Processing
MilliporeSigma: 'Viral vectors will dominate the next decade’
MilliporeSigma: 'Viral vectors will dominate the next decade’
Aug 9, 2021
|
1 Min Read
byMillie Nelson
Amgen forks out $550m to build drug substance facility in NC
Facilities & Capacity
Amgen forks out $550m to build drug substance facility in NC
Amgen forks out $550m to build drug substance facility in NC
Aug 6, 2021
|
1 Min Read
byMillie Nelson
Thermo: Cell & gene therapy key to further growth in 2021
Upstream & Downstream Processing
Thermo: Cell & gene therapy key to further growth in 2021
Thermo: Cell & gene therapy key to further growth in 2021
Aug 5, 2021
|
1 Min Read
byGareth Macdonald
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Deal-Making
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Aug 5, 2021
|
1 Min Read
byMillie Nelson
Media Management: A Critical Consideration Before Intensification
Sponsored Content
Media Management: A Critical Consideration Before Intensification
Media Management: A Critical Consideration Before Intensification
Aug 4, 2021
|
1 Min Read
byBPI Contributor
Ring raises $117m to fund development of anellovectors
Facilities & Capacity
Ring raises $117m to fund development of anellovectors
Ring raises $117m to fund development of anellovectors
Aug 4, 2021
|
1 Min Read
byGareth Macdonald

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024